Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1152-1161

  Hu, Yongfei ^a,b,c   Zhu, Yuying ^a,b   Ma, Yanan ^a,b,d   Liu, Fei ^d   Lu, Na ^a,b   Yang, Xi ^a,b   Luan, Chunguang ^a,b   Yi, Yong ^e   Zhua, Baoli ^a,b,c  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b Beijing Key Laboratory of Microbial Drug Resistance and Resistome   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ANHUI UNIVERSITY   (China)

^e 306 HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DORIPENEM; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLONE DERIVATIVE; SULFAMETHOXAZOLE; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOINFORMATICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; TRANSPOSON; ACHROMOBACTER DENITRIFICANS; BACTERIAL GENOME; DRUG EFFECTS; GENETICS; MULTIDRUG RESISTANCE;

ACHROMOBACTER DENITRIFICANS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL;

EID: 84921788511     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04260-14     Document Type: Article

References (48)

1. Yabuuchi E, Kawamura Y, Kosako Y, Ezaki T. 1998. Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov. Microbiol Immunol 42:429-438. http://dx.doi.org/10.1111/j.1348 -0421.1998.tb02306.x.
2. Gomez-Cerezo J, Suarez I, Rios J, Pena P, Garcia de Miguel M, De Jose M, Monteagudo O, Linares P, Barbado-Cano A, Vazquez J. 2003. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol 22:360-363. http://dx.doi.org/10.1007/s10096-003 -0925-3.
3. Saiman L, Siegel J. 2004. Infection control in cystic fibrosis. Clin Microbiol Rev 17:57-71. http://dx.doi.org/10.1128/CMR.17.1.57-71.2004.
4. Almuzara M, Limansky A, Ballerini V, Galanternikc L, Famigliettia A, Vaya C. 2010. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. Int J Antimicrob Agents 35:68-71. http://dx.doi.org/10.1016/j.ijantimicag.2009 .08.015.
5. Glupczynski Y, Hansen W, Freney J, Yourassowsky E. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother 32:276-278. http://dx.doi .org/10.1128/AAC.32.2.276.
6. Holmes B, Snell J, Lapage S. 1977. Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol 30:595-601. http://dx.doi.org/10 .1136/jcp.30.7.595.
7. Rolston KV, Messer M. 1990. The in-vitro susceptibility of Alcatigenes denitrificans subsp. xylosoxidans to 40 antimicrobial agents. J Antimicrob Chemother 26:857-859.
8. Bador J, Amoureux L, Duez J-M, Drabowicz A, Siebor E, Llanes C, Neuwirth C. 2011. First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM. Antimicrob Agents Chemother 55:4912-4914. http://dx.doi.org/10.1128/AAC.00341-11.
9. Bador J, Amoureux L, Blanc E, Neuwirth C. 2013. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrob Agents Chemother 57: 603-605. http://dx.doi.org/10.1128/AAC.01243-12.
10. Doi Y, Poirel L, Paterson DL, Nordmann P. 2008. Characterization of a naturally occurring classD β-lactamase from Achromobacter xylosoxidans. Antimicrob Agents Chemother 52:1952-1956. http://dx.doi.org/10.1128 /AAC.01463-07.
11. Iyobe S, Kusadokoro H, Takahashi A, Yomoda S, Okubo T, Nakamura A, O'Hara K. 2002. Detection of a variant metallo-β-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans strain. Antimicrob Agents Chemother 46:2014. http://dx.doi .org/10.1128/AAC.46.6.2014-2016.2002.
12. Yamamoto M, Nagao M, Hotta G, Matsumura Y, Matsushima A, Ito Y, Takakura S, Ichiyama S. 2012. Molecular characterization of IMP-type metallo- β -lactamases among multidrug-resistant Achromobacter xylosoxidans. J Antimicrob Chemother 67:2110-2113. http://dx.doi.org/10 .1093/jac/dks179.
13. VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother 45: 1249. http://dx.doi.org/10.1128/AAC.45.4.1249-1253.2001.
14. VIM-2-containing class 1 integron. Diagn Microbiol Infect Dis 53:215-220. http: //dx.doi.org/10.1016/j.diagmicrobio.2005.06.018.
15. Neuwirth C, Freby C, Ogier-Desserrey A, Perez-Martin S, Houzel A, Péchinot A, Duez J, Huet F, Siebor E. 2006. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg Infect Dis 12: 1737. http://dx.doi.org/10.3201/eid1211.060143.
16. El Salabi A, Borra PS, Toleman MA, Samuelsen O, Walsh TR. 2012. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother 56:2241-2245. http://dx.doi.org/10 .1128/AAC.05640-11.
17. Wozniak RA, Waldor MK. 2010. Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 8:552-563. http://dx.doi.org/10.1038/nrmicro2382.
18. Levesque C, Piche L, Larose C, Roy PH. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39:185-191. http://dx.doi.org/10.1128/AAC.39.1.185.
19. Yabuuchi E, Oyama A. 1971. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol 15:477. http://dx.doi.org/10.1111/j .1348-0421.1971.tb00607.x.
20. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement, document M100-S21. Clinical Laboratory and Standards Institute, Wayne, PA.
21. Cox MP, Peterson DA, Biggs PJ. 2010. SolexaQA: at-a-glance quality assessment of Illumina second-generation sequencing data. BMC Bioinformatics 11:485. http://dx.doi.org/10.1186/1471-2105-11-485.
22. Delcher AL, Bratke KA, Powers EC, Salzberg SL. 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23:673-679. http://dx.doi.org/10.1093/bioinformatics/btm009.
23. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. http://dx.doi.org/10.1186 /1471-2164-9-75.
24. Liu B, Pop M. 2009. ARDB: antibiotic resistance genes database. Nucleic Acids Res 37:D443-D447. http://dx.doi.org/10.1093/nar/gkn656.
25. Tatusov RL, Fedorova ND, Jackson JD, Jacobs AR, Kiryutin B, Koonin EV, Krylov DM, Mazumder R, Mekhedov SL, Nikolskaya AN. 2003. The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4:41. http://dx.doi.org/10.1186/1471-2105-4-41.
26. Boeckmann B, Bairoch A, Apweiler R, Blatter M-C, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I. 2003. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31:365-370. http://dx.doi.org/10.1093/nar/gkg095.
27. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Res 19:1639-1645. http://dx.doi.org/10.1101/gr .092759.109.
28. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
29. Langille MG, Brinkman FS. 2009. IslandViewer: an integrated interface for computational identification and visualization of genomic islands. Bioinformatics 25:664-665. http://dx.doi.org/10.1093/bioinformatics/btp030.
30. Larkin M, Blackshields G, Brown N, Chenna R, McGettigan PA, Mc-William H, Valentin F, Wallace IM, Wilm A, Lopez R. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948. http://dx.doi.org /10.1093/bioinformatics/btm404.
31. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x.
32. Spilker T, Vandamme P, LiPuma JJ. 2012. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol 50:3010-3015. http://dx.doi.org /10.1128/JCM.00814-12.
33. Levesque R, Letarte R, Pechère J-C. 1983. Comparative study of the beta-lactamase activity found in Achromobacter. Can J Microbiol 29:819-826. http://dx.doi.org/10.1139/m83-133.
34. Decré D, Arlet G, Bergogne-Berezin E, Philippon A. 1995. Identification of a carbenicillin-hydrolyzing β-lactamase in Alcaligenes denitrificans subsp. xylosoxydans. Antimicrob Agents Chemother 39:771-774. http: //dx.doi.org/10.1128/AAC.39.3.771.
35. Philippon A, Mensah K, Fournier G, Freney J. 1990. Two resistane phenotypes to β-lactams of Alcaligenes denitrificans subsp. xylosoxydans in relation to β-lactamase ypes. J Antimicrob Chemother 25:698-700.
36. Fujii T, Sato K, Inoue M, Mitsuhashi S. 1985. Purification and properties of a β-lactamase from Alcaligenes dentrificans subsp. xylosoxydans. J Antimicrob Chemother 16:297-304. http://dx.doi.org/10.1093/jac/16.3.297.
37. Webber M, Piddock L. 2003. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51:9-11. http://dx.doi.org /10.1093/jac/dkg050.
38. Li X, Hu Y, Gong J, Zhang L, Wang G. 2013.Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle. Appl Microbiol Biotechnol 97:6413-6425. http://dx.doi.org/10.1007/s00253-013 -5018-3.
39. Jakobsen TH, Hansen MA, Jensen P∅, Hansen L, Riber L, Cockburn A, Kolpen M, Rønne Hansen C, Ridderberg W, Eickhardt S, Hansen M, Kerpedjiev P, Alhede M, Qvortrup K, Burmølle M, Moser C, Kühl M, Ciofu O, Givskov M, Sørensen SJ, Høiby N, Bjarnsholt T. 2013. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLoS One 8:e68484. http://dx.doi.org/10.1371/journal.pone .0068484.
40. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plésiat P. 2007. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 51:1016-1021. http://dx.doi.org/10.1128/AAC.00704-06.
41. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22:582-610. http://dx.doi.org/10.1128/CMR.00040-09.
42. Liebert CA, Hall RM, Summers AO. 1999. Transposon Tn21, flagship of the floating genome. Microbiol Mol Biol Rev 63:507-522.
43. Baker-Austin C, Wright MS, Stepanauskas R, McArthur J. 2006. Coselection of antibiotic and metal resistance. Trends Microbiol 14:176-182. http://dx.doi.org/10.1016/j.tim.2006.02.006.
44. Bi D, Xu Z, Harrison EM, Tai C, Wei Y, He X, Jia S, Deng Z, Rajakumar K, Ou H-Y. 2012. ICEberg: a Web-based resource for integrative and conjugative elements found in Bacteria. Nucleic Acids Res 40:D621-D626. http://dx.doi.org/10.1093/nar/gkr846.
45. Handa N, Kobayashi I. 1999. Post-segregational killing by restriction modification gene complexes: observations of individual cell deaths. Biochimie 81:931-938. http://dx.doi.org/10.1016/S0300-9084(99)00201-1.
46. Kobayashi I. 2001. Behavior of restriction-modification systems as selfish mobile elements and their impact on genome evolution. Nucleic Acids Res 29:3742-3756. http://dx.doi.org/10.1093/nar/29.18.3742.
47. Van Melderen L, De Bast MS. 2009. Bacterial toxin-antitoxin systems: more than selfish entities? PLoS Genet 5:e1000437. http://dx.doi.org/10 .1371/journal.pgen.1000437.
48. Wozniak RA, Waldor MK. 2009. A toxin-antitoxin system promotes the maintenance of an integrative conjugative element. PLoS Genet 5:e1000439. http://dx.doi.org/10.1371/journal.pgen.1000439.